PAD2: A potential target for tumor therapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-09 · 1878 (5) · 188931
DOI: 10.1016/j.bbcan.2023.188931 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-09. Verfasst von Yi Teng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China; Department of Immunology, Jiangsu Key Laboratory of Labor…. Hauptthemen laut MEDLINE: Citrullination, Protein Processing, Post-Translational. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 126 Literaturangaben.
Abstract (Originalsprache)
Peptide arginine deiminase 2(PAD2) catalyzes the conversion of arginine residues on target proteins to citrulline residues in the presence of calcium ions. This particular posttranslational modification is called citrullination. PAD2 can regulate the transcriptional activity of genes through histone citrullination and nonhistone citrullination. In this review, we summarize the evidence from recent decades and systematically illustrate the role of PAD2-mediated citrullination in tumor pathology and the regulation of tumor-associated immune cells such as neutrophils, monocytes, macrophages and T cells. Several PAD2-specific inhibitors are also presented to discuss the feasibility of anti-PAD2 therapy to treat tumors and the urgent problems to be solved. Finally, we review some recent developments in the development of PAD2 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China; Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Chi…
- Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
- Department of Laboratory Medicine, the Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.
- Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China; Department of Laboratory Medicine, the Affiliated People's Hospital, Jiangsu University,…
- Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China. Electronic address: jsyinkai@163.com.
Zitieren
APA
Teng, Y., Chen, Y., Tang, X., Wang, S., & Yin, K. (2023). PAD2: A potential target for tumor therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(5), 188931. https://doi.org/10.1016/j.bbcan.2023.188931
Vancouver
Teng Y, Chen Y, Tang X, Wang S, Yin K. PAD2: A potential target for tumor therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(5):188931. doi:10.1016/j.bbcan.2023.188931
BibTeX
@article{Teng2023,
author = {Teng, Yi and Chen, Yuhang and Tang, Xinyi and Wang, Shengjun and Yin, Kai},
title = {PAD2: A potential target for tumor therapy},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {5},
pages = {188931},
doi = {10.1016/j.bbcan.2023.188931}
}
EUVIMED